Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.95B
Enterprise Value4.54B
P/E Ratio-11.11
PEG Ratio0.08
Price/Sales Ratio4.03
Price/Book Ratio1.88
Enterprise/Revenue4.7
Enterprise/EBITDA-26.82

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.36
Operating Margin-0.38
AD

Management Effectiveness

Return On Assets-0.09
Return On Equity-0.16

Income Statement

Revenue789.42M
Revenue/Share2.54
Gross Profit297.81M
EBITDA-183.87M
Net Income-339.63M
Diluted EPS-1.07

Balance Sheet

Total Cash386.7M
Total Cash/Share1.22
Total Debt892.7M
Total Debt/Equity0.52
Current Ratio0.72
Book Value Per Share5.47

Price History

52-Week Change-29.84
52-Week High17.19
52-Week Low8.93
Moving Average 50 Days12.76
Moving Average 200 Days11.79

Statistics

Average Volume23.2M
Shares Outstanding316.35M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.08
Last Split Factor3:2
Last Split DateJune 13, 2018
AD